Oxford Immunotec Global PLC (OXFD) - Comprehensive Stock Analysis & Investment Research
Deep dive into Oxford Immunotec Global PLC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Oxford Immunotec Global PLC, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Oxford Immunotec Global PLC: Oxford Immunotec Global PLC operates in the Manufacturing sector, making it an emerging small-cap investment.
Oxford Immunotec Global PLC (Stock Symbol: OXFD) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.
The organization employs approximately 243 professionals worldwide and operates under the strategic leadership of CEO Peter Wrighton-Smith.
The company has established itself as an emerging investment opportunity with substantial growth potential.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Oxford Immunotec Global PLC's revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Oxford Immunotec Global PLC: With $331M in annual revenue and 6.6% net margin, the company demonstrates solid profitability.
Annual Revenue: $331 million generating a 6.6% net profit margin .
Market Capitalization: $330 million - Classified as a small-cap investment offering high growth potential.
Return on Equity (ROE): 24.0% - Exceptional shareholder return efficiency, indicating strong management effectiveness.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Oxford Immunotec Global PLC stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Oxford Immunotec Global PLC: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Oxford Immunotec Global PLC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Oxford Immunotec Global PLC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Oxford Immunotec Global PLC: Strong free cash flow generation demonstrates solid operational efficiency.
Oxford Immunotec Global PLC strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .
The company demonstrates robust operational efficiency through strong free cash flow generation of $123 million annually.
The company maintains a healthy 75.1% gross margin, indicating strong pricing power and operational efficiency.